Ledipasvir 90mg/Sofosbuvir 400 mg
GILEAD IN-US-337-4109
Approved small_molecule terminated
Quick answer
Ledipasvir 90mg/Sofosbuvir 400 mg for Hepatocellular Carcinoma is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Hepatocellular Carcinoma
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated